Perhaps more worryingly, in the PCPT study the risk of detecting high grade prostate cancers increases threefold (5.7% to 14.6%) when a PSA cut-off of 5.0 ng/ml rather than 2.0 ng/ml is used. This evidence concerns the gene KLK3 and Familial prostate cancer.